Skip to main content
. 2021 Jun 18;63(12):759–762. doi: 10.11622/smedj.2021082

Figure 2.

Figure 2

Chart shows the timeline of Case 2's symptoms, clinical progress, laboratory findings and immunosuppression management. The patient was started on lopinavir/ritonavir on admission, but it was ceased after three days in view of gastrointestinal symptoms. High tacrolimus trough levels were observed. Clinical deterioration occurred on Day 8 of admission, corresponding to the time point of worsening inflammatory markers. The patient was initiated on haemodialysis due to oliguria and remained dialysis dependent after de-isolation on Day 33 of illness. He was repatriated well on Day 42. ✓: Session of RRT, ×: immunosuppression withheld, EON: every other night, IL-6: interleukin-6, LPV/R: lopinavir/ritonavir, PCR: polymerase chain reaction; RRT: renal replacement therapy